You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 205920


✉ Email this page to a colleague

« Back to Dashboard


NDA 205920 describes PRIMATENE MIST, which is a drug marketed by Armstrong Pharms and Wyeth Cons and is included in two NDAs. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the PRIMATENE MIST profile page.

The generic ingredient in PRIMATENE MIST is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
Summary for 205920
Tradename:PRIMATENE MIST
Applicant:Armstrong Pharms
Ingredient:epinephrine
Patents:1
Suppliers and Packaging for NDA: 205920
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PRIMATENE MIST epinephrine AEROSOL, METERED;INHALATION 205920 NDA Armstrong Pharmaceuticals, Inc. 17270-5530 17270-5530-0 1 INHALER in 1 CARTON (17270-5530-0) / 160 AEROSOL in 1 INHALER

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:AEROSOL, METERED;INHALATIONStrength0.125MG/INH
Approval Date:Nov 7, 2018TE:RLD:Yes
Patent:⤷  Sign UpPatent Expiration:Jan 26, 2026Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.